Market Cap 4.49M
Revenue (ttm) 60,000.00
Net Income (ttm) -37.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -62,350.00%
Debt to Equity Ratio 0.00
Volume 11,452,300
Avg Vol 26,438,498
Day's Range N/A - N/A
Shares Out 64.55M
Stochastic %K 44%
Beta 3.50
Analysts Strong Buy
Price Target N/A

Latest News on ONCO

Onco-Innovations Uplists to Cboe Canada

May 22, 2025, 10:00 AM EDT - 15 days ago

Onco-Innovations Uplists to Cboe Canada


Crude Oil Rises; Onconetix Shares Spike Higher

Sep 27, 2024, 2:41 PM EDT - 9 months ago

Crude Oil Rises; Onconetix Shares Spike Higher


Blue Water Biotech Issues Letter to Shareholders

Oct 30, 2023, 7:00 AM EDT - 1 year ago

Blue Water Biotech Issues Letter to Shareholders